BMS-IM101-603
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Bristol-Myers Squibb Company
Start Date
September 12, 2017
End Date
August 31, 2019
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Bristol-Myers Squibb Company
Start Date
September 12, 2017
End Date
August 31, 2019